Literature DB >> 25234817

Inhibiting the Th17/IL-17A-related inflammatory responses with digoxin confers protection against experimental abdominal aortic aneurysm.

Zhanjie Wei1, Yu Wang1, Kailun Zhang1, Yaohang Liao1, Ping Ye1, Jie Wu1, Yang Wang1, Feifei Li1, Yufeng Yao1, Yanzhao Zhou1, Jinping Liu2.   

Abstract

OBJECTIVE: T helper 17 cells and interleukin-17A have been implicated in the progression of abdominal aortic aneurysm (AAA). Retinoic acid-related orphan receptor gamma thymus, the master transcription factor of T helper 17 cell differentiation, is selectively antagonized by digoxin. However, the effect of antagonizing retinoic acid-related orphan receptor gamma thymus on AAA has not been investigated. APPROACH AND
RESULTS: We used human aortic sample analysis and 2 different experimental AAA models: (a) Angiotensin II (Ang II)-induced ApoE(-/-) male mice (Ang II/APOE model) and (b) porcine pancreatic elastase perfusion C57BL/6 mice (porcine pancreatic elastase/C57 model). In the Ang II/APOE model, all mice (n=80) were divided into 4 groups: sham group (saline+0.5% dimethyl sulfoxide treatment), control group (Ang II+0.5% dimethyl sulfoxide treatment), low-dose group (Ang II+low-dose digoxin, 20 μg/d per mouse), and high-dose group (Ang II+high-dose digoxin, 40 μg/d per mouse). All treatments began on day 0 after surgery. Efficacy was determined via aortic diameter and systolic blood pressure measurements, histopathology and protein expression, and flow cytometry analysis when euthenized. Human aortic tissue analysis showed that both interleukin-17A and retinoic acid-related orphan receptor gamma thymus increased in AAA tissues. The low-dose and high-dose groups had AAA incidences of 60% and 35%, respectively, compared with 70% in the control group. The T helper 17- and interleukin-17A-related inflammatory responses were dose-dependently attenuated by digoxin treatment. Digoxin was also highly effective in the porcine pancreatic elastase/C57 model.
CONCLUSIONS: Digoxin attenuates experimental AAA progression in a model-independent manner. Antagonizing retinoic acid-related orphan receptor gamma thymus activity by digoxin may become a novel strategy for nonsurgical AAA treatment.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  IL-17A; abdominal aortic aneurysm; digoxin; inflammation

Mesh:

Substances:

Year:  2014        PMID: 25234817     DOI: 10.1161/ATVBAHA.114.304435

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  30 in total

Review 1.  Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy.

Authors:  Matthew A Dale; Melissa K Ruhlman; B Timothy Baxter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-04       Impact factor: 8.311

Review 2.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

3.  [Postoperative changes of Th17/Treg balance in patients with intracranial aneurysm rupture].

Authors:  Zai Liang; Hong-Jian Jian; Qian-Yi Lin; Sai-Hua Luo; Xiao-Peng Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-04-20

4.  Digoxin reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Huairui Shi; Xiaobo Mao; Yucheng Zhong; Yuzhou Liu; Xiaoqi Zhao; Kunwu Yu; Ruirui Zhu; Yuzhen Wei; Jianghao Zhu; Haitao Sun; Yi Mao; Qiutang Zeng
Journal:  Br J Pharmacol       Date:  2016-03-11       Impact factor: 8.739

Review 5.  Abdominal aortic aneurysm: novel mechanisms and therapies.

Authors:  Frank M Davis; Debra L Rateri; Alan Daugherty
Journal:  Curr Opin Cardiol       Date:  2015-11       Impact factor: 2.161

6.  Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.

Authors:  Haojun Xuan; Baohui Xu; Wei Wang; Hiroki Tanaka; Naoki Fujimura; Masaaki Miyata; Sara A Michie; Ronald L Dalman
Journal:  J Vasc Surg       Date:  2017-04-20       Impact factor: 4.268

7.  Cytokine amplification and macrophage effector functions in aortic inflammation and abdominal aortic aneurysm formation.

Authors:  Talha Ijaz; Ronald G Tilton; Allan R Brasier
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

8.  Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.

Authors:  Wei Wang; Baohui Xu; Haojun Xuan; Yingbin Ge; Yan Wang; Lixin Wang; Jianhua Huang; Weiguo Fu; Sara A Michie; Ronald L Dalman
Journal:  J Vasc Surg       Date:  2017-12-11       Impact factor: 4.268

Review 9.  Ruptured abdominal aortic aneurysm-epidemiology, predisposing factors, and biology.

Authors:  Thomas Schmitz-Rixen; M Keese; M Hakimi; A Peters; D Böckler; K Nelson; R T Grundmann
Journal:  Langenbecks Arch Surg       Date:  2016-03-21       Impact factor: 3.445

10.  Description of human AAA by cytokine and immune cell aberrations compared to risk-factor matched controls.

Authors:  S Keisin Wang; Linden A Green; Ashley R Gutwein; Natalie A Drucker; Raghu L Motaganahalli; Alok K Gupta; Andres Fajardo; Michael P Murphy
Journal:  Surgery       Date:  2018-04-30       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.